Treatment with bakumondoto significantly improved cough severity during the first treatment period ( week 0 vs. week 8 , p = 0.004 ) and showed a trend to decrease during the second treatment period ( week 8 vs. week 16 , p = 0.129 ) assessed by the VAS .
